Article

Podcast: The Case for Upgrading existing HPLC Assays to UPLC

The Case for Upgrading existing HPLC Assays to UPLC

Eric Hill of Impact Analytical discusses the emergence new analytical technologies, specifically UPLC. He outlines the advantages of converting existing HPLC assays to UPLC, including both increased performance and cost savings. With minimal upfront investment, the long term gains are significant.


Add this Podcast feed to your media player

WHITEPAPERS


Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
PharmTech Weekly News Roundup
© 2025 MJH Life Sciences

All rights reserved.